Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pandemic Influenza Immunization”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 0 results

Not applicableUnknownNCT04569019
What this trial is testing

Attitudes Towards Influenza Vaccinations Among the Healthcare Workers of Medical University of Warsaw

Who this might be right for
Vaccnation in HCW
Medical University of Warsaw 1,000
Not applicableStudy completedNCT01289418
What this trial is testing

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Who this might be right for
Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network 6,525
Testing effectiveness (Phase 2)Study completedNCT00530660
What this trial is testing

Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)

Who this might be right for
Influenza
Alachua Government Services, Inc. 141
Early research (Phase 1)Study completedNCT00798343
What this trial is testing

Heterosubtypic Immune Responses to Influenza in Older People

Who this might be right for
Influenza
University Hospitals, Leicester 292
Testing effectiveness (Phase 2)Study completedNCT00386542
What this trial is testing

Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children

Who this might be right for
Influenza
Pedro Moro 450
Not applicableStudy completedNCT01066169
What this trial is testing

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

Who this might be right for
HIV
Leiden University Medical Center 104
Not applicableStudy completedNCT01206114
What this trial is testing

Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11

Who this might be right for
Influenza Caused by the 2009 H1N1 Influenza Virus
Finnish Institute for Health and Welfare 2,351
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Testing effectiveness (Phase 2)Study completedNCT06727058
What this trial is testing

Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and Older

Who this might be right for
Influenza Immunization
Sanofi Pasteur, a Sanofi Company 276
Early research (Phase 1)Study completedNCT01059617
What this trial is testing

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Who this might be right for
Influenza
GlaxoSmithKline 133
Post-approval studies (Phase 4)UnknownNCT01151644
What this trial is testing

Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

Who this might be right for
Rheumatoid ArthritisSpondyloarthritisSystemic Lupus Erythematosus (SLE)+9 more
University of Sao Paulo 5,000
Testing effectiveness (Phase 2)Study completedNCT05874713
What this trial is testing

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Who this might be right for
Influenza, HumanInfectionsRespiratory Tract Infections+2 more
Seqirus 480
Testing effectiveness (Phase 2)Study completedNCT00306995
What this trial is testing

Safety Study of Pandemic Candidate Influenza Vaccines in the Elderly Population

Who this might be right for
InfluenzaInfluenza Vaccines
GlaxoSmithKline 385